XML 37 R26.htm IDEA: XBRL DOCUMENT v3.20.2
EARNINGS (LOSS) PER SHARE (Tables)
9 Months Ended
Sep. 30, 2020
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
A reconciliation of the numerators and denominators of the basic and diluted loss per share calculations for the three and nine months ended September 30, 2020 and 2019 were as follows:

 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
 
2020
 
2019
 
2020
 
2019
 
Loss per share ("EPS"):
 
 

 
 

 
 

 
 

 
EPS - basic and diluted:
 
 
 
 
 
 
 
 
 
(Loss) earnings per share from continuing operations
 
$
(0.41
)
 
$
0.11

 
$
(0.84
)
 
$
(0.74
)
 
Earnings (loss) per share from discontinued operations
 

 
0.01

 

 
(0.04
)
 
(Loss) earnings per share
 
$
(0.41
)
 
$
0.12

 
$
(0.84
)
 
$
(0.77
)
 
EPS numerator - basic and diluted:
 
 
 
 
 
 
 
 
 
(Loss) income from continuing operations
 
$
(1,157
)
 
$
346

 
$
(2,440
)
 
$
(2,325
)
 
Income (loss) from discontinued operations
 

 
18

 

 
(113
)
 
Net (loss) income
 
$
(1,157
)
 
$
364

 
$
(2,440
)
 
$
(2,438
)
 
EPS denominator (in thousands):
 
 

 
 

 
 

 
 
 
Weighted average common stock outstanding - basic
 
2,858

 
3,082

 
2,920

 
3,150

 
Common stock equivalents: stock options and restricted stock units (a)
 

(a) 
36

 

(a) 

(a) 
Weighted average number of common stock outstanding - diluted
 
2,858

 
3,118

 
2,920

 
3,150

 


(a)
The diluted weighted average number of shares of common stock outstanding did not differ from the basic weighted average number of shares of common stock outstanding because the effects of any potential common stock equivalents (see Note 6 for further details on outstanding stock options and unvested restricted stock units) were anti-dilutive and therefore not included in the calculation of the denominator of dilutive earnings per share.
Schedule of antidilutive securities excluded from computation of earnings per share
The weighted average number of shares outstanding used in the computation of diluted net income (loss) per share for the three and nine months ended September 30, 2020 and 2019 did not include the effect of the following potentially outstanding shares of common stock because the effect would have been anti-dilutive:
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2020
 
2019
 
2020
 
2019
Unvested restricted stock units
 
18,174

 

 
18,174

 
66,933

Stock options
 
5,000

 
5,000

 
5,000

 
5,000

Total
 
23,174

 
5,000

 
23,174

 
71,933